(April 24, 2024) Webinar: Accelerating the Delivery of New Treatments for Children with Neuroblastoma
(April 24, 2024) Webinar: Accelerating the Delivery of New Treatments for Children with
Workshop: Manifestation of Microvascular Dysfunction in a Rat Model of Diabetic Cardiomyopathy: Teasing Apart Sex-Dependent Differences with Multimodality Imaging
Workshop: Manifestation of Microvascular Dysfunction in a Rat Model of Diabetic Cardiomyopathy: Teasing Apart Sex-Dependent Differences with Multimodality Imaging
Scintica will be at the American Physiological Summit 2024 (APS 2024) in Long Beach, CA – we will be at booth 139! We also invite you to visit us at the Innovation Stage on April 6th from 10:15am – 11am for our workshop by speaker, Sadi Loai, while he presents his work titled: Manifestation of Microvascular Dysfunction in a Rat Model of Diabetic Cardiomyopathy: Teasing Apart Sex-Dependent Differences with Multimodality Imaging.
WHEN: April 6, 2024 @ 10:15am – 11am
WHERE: Long Beach Convention Center, Innovation Stage
SPEAKER: Sadi Loai, PhD (Product Specialist, Scintica)
SPEAKER: Sadi Loai, PhD (Product Specialist, Scintica)
.
OVERVIEW:
Microvascular dysfunction has been implicated as the primary hallmark of several cardiac and inflammatory diseases (e.g., diabetes, heart failure, kidney disease), affecting millions of people worldwide. The onset and progression of microvascular disease is driven by vascular inflammation and is characterized by impaired vasomodulation. The ability to noninvasively assess microvascular function is essential to assessing intact microvascular reactivity. In this session we will discuss the findings from a recent study which employed multimodality imaging (MRI, ultrasound, photoacoustic, laser Doppler) along with standardized clinical testing, with the purpose of understanding the progression of diabetic cardiomyopathy while teasing apart sex-dependent differences.
Microvascular dysfunction has been implicated as the primary hallmark of several cardiac and inflammatory diseases (e.g., diabetes, heart failure, kidney disease), affecting millions of people worldwide. The onset and progression of microvascular disease is driven by vascular inflammation and is characterized by impaired vasomodulation. The ability to noninvasively assess microvascular function is essential to assessing intact microvascular reactivity. In this session we will discuss the findings from a recent study which employed multimodality imaging (MRI, ultrasound, photoacoustic, laser Doppler) along with standardized clinical testing, with the purpose of understanding the progression of diabetic cardiomyopathy while teasing apart sex-dependent differences.
10:15 am - 11:00 am
Explore our Past Webinars
(March 14, 2024) Webinar: Validation of DEXA for Longitudinal Quantification of Tumor Burden in A Murine Model of Pancreatic Ductal Adenocarcinoma
(March 14, 2024) Webinar: Validation of DEXA for Longitudinal Quantification of Tumor Burden
(March 13, 2024) Overview of Preclinical Small Animal and Multimodal Imaging
(March 13, 2024) Overview of Preclinical Small Animal and Multimodal Imaging Overview:In this
(February 29, 2024) Webinar: In Vivo Photoacoustic Tomography in Assessing Acute Systemic Vasoactivity: A Noninvasive Systemic Myography Tool
(February 29, 2024) Webinar: In Vivo Photoacoustic Tomography in Assessing Acute Systemic Vasoactivity:
(September 20, 2023) Webinar: An introduction to Photoacoustic Imaging
(September 20, 2023) Webinar: An Introduction to Photoacoustic Imaging Overview: Dr. Lawrence Yip
(September 13, 2023) Webinar: Seeing Double: Preclinical Multiplexed PET for Dual Isotope Imaging
(September 13, 2023) Webinar: Seeing Double: Preclinical Multiplexed PET for Dual Isotope Imaging